Blog
RSS FeedPosted by Michael Wonder on 08 Aug 2019
The economics of biologic drugs
8 August 2019 - The market for biologic drugs in the United States is large and growing. ...
Posted by Michael Wonder on 27 Jun 2019
FDA takes new step to help advance the transition of certain biological products
27 June 2019 - Today the U.S. FDA issued a proposed rule to amend its regulations on the use of master ...
Posted by Michael Wonder on 11 Oct 2016
Biotech sector crafts response to R&D tax incentive review
11 October 2016 - AusBiotech members are invited to gather at briefings in Sydney, Brisbane and Melbourne to contribute to ...
Posted by Michael Wonder on 06 Oct 2016
Why the drug industry and its critics are both wrong about how R&D spending affects pricing
6 October 2016 - The drug industry often claims that high prices are due to its high R&D costs, while ...
Posted by Michael Wonder on 05 Oct 2016
Bill Ferris defends R&D reform proposals
5 October 2016 - Fewer than 1% of the 10,000 companies receiving cash refunds as part of the research and development ...
Posted by Michael Wonder on 03 Aug 2016
New biomedical fund to capitalise on our research and entrepreneurial strengths
3 August 2016 - A new fund to accelerate the development and commercialisation of Australian biomedical discoveries is now officially launched. ...
Posted by Michael Wonder on 08 Jun 2016
New fund set up to support research into medicines usage in NZ
8 June 2016 - Why do people not take all the medicine prescribed for them? Why are there differences in the ...
Posted by Michael Wonder on 10 Dec 2015
Fund to bridge biomedical research to market gaps
10 December 2015 - The Australian Government’s $250 million Biomedical Translation Fund will bridge the gap between research and commercialisation of ...